We spend our days looking at them, talking to them, and touching them. They increasingly consume our time, attention and money. We are addicted to our digital devices — or, more precisely, the digital experiences they give us. A study analyzed the growing problem with digital addiction and how marketers as well as app developers contribute to this 21st-century phenomenon.
Read moreAspiring parents should both avoid drinking alcohol prior to conception to protect against congenital heart defects.
Read moreSince the early 2000s, Russia has seen significant declines in overall alcohol consumption, and a new review shows that there has been a parallel, steep decline in the country's mortality rates as well.
Read moreAnalysis of corruption cases among customs officers and Border Patrol agents reveals alarming trends depending on their years of service.
Read moreStriking a power pose before an important meeting or interview is not going to boost your confidence or make you feel more powerful, says a researcher. A psychology professor reviewed nearly 40 studies on the topic and found not a single one supports the claims that power posing works.
Read moreFlavor, safety and family attitude toward vaping are among the greatest factors influencing teenage perception of e-cigarettes, new research finds.
Read moreIt is not possible to achieve the sustainable development goals (SDG) if science does not contribute with cross-disciplinary knowledge and understanding of how systems are interconnected.
Read moreAccording to a new study the distribution of drug molecules within the brain can be improved by utilizing LAT1, which is expressed highly in the brain.
Read moreChronic obstructive pulmonary disease (COPD) is a progressive lung disease that's often associated with a variety of health problems, including chronic muscle pain and insomnia. Psychoactive drug classes, like cannabinoids, are often prescribed to help reduce pain, promote sleep and decrease breathlessness. A study has found that older adults with COPD were twice as likely to use prescription synthetic oral cannabinoids compared to older adults without COPD, raising safety concerns.
Read moreResearchers describe a new use of leukemia drug, nilotinib, to treat a subtype of medulloblastoma, a deadly pediatric brain cancer.
Read more